Gemmer Asset Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-105
| Closed | -$6K | – | 521 |
|
|
2022
Q1 | $6K | Hold |
105
| – | – | ﹤0.01% | 871 |
|
|
2021
Q4 | $6K | Hold |
105
| – | – | ﹤0.01% | 916 |
|
|
2021
Q3 | $7K | Hold |
105
| – | – | ﹤0.01% | 831 |
|
|
2021
Q2 | $7K | Hold |
105
| – | – | ﹤0.01% | 947 |
|
|
2021
Q1 | $12K | Hold |
105
| – | – | ﹤0.01% | 692 |
|
|
2020
Q4 | $12K | Hold |
105
| – | – | ﹤0.01% | 612 |
|
|
2020
Q3 | $9K | Hold |
105
| – | – | ﹤0.01% | 651 |
|
|
2020
Q2 | $9K | Hold |
105
| – | – | ﹤0.01% | 636 |
|
|
2020
Q1 | $10K | Hold |
105
| – | – | ﹤0.01% | 513 |
|
|
2019
Q4 | $12K | Hold |
105
| – | – | ﹤0.01% | 587 |
|
|
2019
Q3 | $13K | Hold |
105
| – | – | ﹤0.01% | 555 |
|
|
2019
Q2 | $13K | Hold |
105
| – | – | ﹤0.01% | 537 |
|
|
2019
Q1 | $9K | Hold |
105
| – | – | ﹤0.01% | 724 |
|
|
2018
Q4 | $11K | Hold |
105
| – | – | ﹤0.01% | 572 |
|
|
2018
Q3 | $12K | Hold |
105
| – | – | ﹤0.01% | 602 |
|
|
2018
Q2 | $9K | Hold |
105
| – | – | ﹤0.01% | 746 |
|
|
2018
Q1 | $8K | Hold |
105
| – | – | ﹤0.01% | 781 |
|
|
2017
Q4 | $6K | Hold |
105
| – | – | ﹤0.01% | 888 |
|
|
2017
Q3 | $5K | Hold |
105
| – | – | ﹤0.01% | 943 |
|
|
2017
Q2 | $4K | Hold |
105
| – | – | ﹤0.01% | 990 |
|
|
2017
Q1 | $4K | Hold |
105
| – | – | ﹤0.01% | 975 |
|
|
2016
Q4 | $4K | Hold |
105
| – | – | ﹤0.01% | 972 |
|
|
2016
Q3 | $4K | Hold |
105
| – | – | ﹤0.01% | 952 |
|
|
2016
Q2 | $3K | Buy |
105
+35
| +50% | +$1.06K | ﹤0.01% | 1025 |
|
|
2016
Q1 | $2K | Sell |
70
-59
| -46% | -$1.91K | ﹤0.01% | 1070 |
|
|
2015
Q4 | $4K | Buy |
129
+17
| +15% | +$551 | ﹤0.01% | 907 |
|
|
2015
Q3 | $4K | Sell |
112
-8
| -7% | -$301 | ﹤0.01% | 887 |
|
|
2015
Q2 | $5K | Hold |
120
| – | – | ﹤0.01% | 842 |
|
|
2015
Q1 | $5K | Buy |
120
+8
| +7% | +$334 | ﹤0.01% | 884 |
|
|
2014
Q4 | $4K | Hold |
112
| – | – | ﹤0.01% | 939 |
|
|
2014
Q3 | $4K | Hold |
112
| – | – | ﹤0.01% | 949 |
|
|
2014
Q2 | $4K | Hold |
112
| – | – | ﹤0.01% | 982 |
|
|
2014
Q1 | $4K | Buy |
+112
| New | +$4.28K | ﹤0.01% | 964 |
|
Other funds holding HAE
LCP
Gemmer Asset Management's HAE Position: Q2 2022 in Review
Gemmer Asset Management sold out of Haemonetics (HAE) in Q2 2022, closing a stake of 105 shares — an estimated $6K sold.
Gemmer Asset Management first reported a position in HAE in Q1 2014 and held it in 33 quarters. The position peaked at $13K in Q3 2019. 241 funds tracked by Wall St. Rank hold HAE as of Q2 2022.
- Gemmer Asset Management reported no remaining Haemonetics position as of Q2 2022 after selling out during the quarter.
- Gemmer Asset Management sold 105 Haemonetics shares in Q2 2022, an estimated $6K.
- Gemmer Asset Management first reported a position in Haemonetics in Q1 2014 and held it in 33 quarters.
- Gemmer Asset Management's Haemonetics position peaked at $13K in Q3 2019.
- 241 funds tracked by Wall St. Rank held Haemonetics as of Q2 2022.
Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.